AstraZeneca forecasts 2021 growth on strong Q4 sales
AstraZeneca has forecast 2021 revenue growth after the Covid-19 vaccine developer beat analysts' estimates for fourth-quarter product sales, as a wide range of therapies helped cushion the hit from the pandemic.
Business
• 11 Feb 21
